LIPO GANTRISIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lipo Gantrisin, and what generic alternatives are available?
Lipo Gantrisin is a drug marketed by Roche and is included in one NDA.
The generic ingredient in LIPO GANTRISIN is sulfisoxazole acetyl. There are three drug master file entries for this compound. Additional details are available on the sulfisoxazole acetyl profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIPO GANTRISIN?
- What are the global sales for LIPO GANTRISIN?
- What is Average Wholesale Price for LIPO GANTRISIN?
Summary for LIPO GANTRISIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 50 |
| Patent Applications: | 1,542 |
| DailyMed Link: | LIPO GANTRISIN at DailyMed |
US Patents and Regulatory Information for LIPO GANTRISIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | LIPO GANTRISIN | sulfisoxazole acetyl | EMULSION;ORAL | 009182-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
